Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir/Pegylated-interferon Plus Ribavirin in HCV GT4
NCT04382339Phase 2Completed
- Sponsor
- Beni Suef University
- Start
- Mar 2015
- Primary completion
- Nov 2015
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of sofosbuvir in hepatitis C virus infection (2 arms), sponsored by Beni Suef University. Primary endpoints: Sustained Virologic Response 12 Weeks Post-treatment and Adverse Events. Started Mar 2015; status: completed.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT04382339.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04382339.